PCI Biotech: European patent for mRNA delivery with fimaNAc
07. September 2023 06:36 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 7 September 2023 – PCI Biotech (OSE: PCIB), a biopharmaceutical company, today announces that the European Patent Office (EPO) has informed PCI Biotech that they intend to grant a new...
PCI Biotech: Employee share option scheme
04. September 2023 04:14 ET
|
PCI Biotech Holding ASA
Oslo, 4 September 2023 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In accordance with the authorisation granted by the...
PCI Biotech: Write-down of share capital registered
01. September 2023 05:04 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 1 September 2023 – PCI Biotech Holding ASA (OSE: PCIB) Reference is made to the resolution made by the Annual General Meeting 25 May 2023, in respect of a write-down of share capital by...
PCI Biotech first half 2023 interim results
31. August 2023 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 31 August 2023 – PCI Biotech (OSE: PCIB), today announces its interim first half 2023 results. Please find enclosed the report and presentation.Highlights review fimaNAc –...
PCI Biotech: Invitation to first half interim 2023 results presentation
25. August 2023 08:30 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 25 August 2023 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2023 interim report on Thursday 31 August 2023, 08:30am – 09:30am CEST (local...
Minutes from Annual General Meeting 2023
25. Mai 2023 05:38 ET
|
PCI Biotech Holding ASA
Oslo, 25 May 2023. The Annual General Meeting in PCI Biotech Holding ASA took place today, 25 May 2023. All the matters on the agenda were approved and the minutes of the Annual General Meeting are...
Disclosure of voting rights for Chairman of the Board
24. Mai 2023 04:43 ET
|
PCI Biotech Holding ASA
Oslo, 24 May 2023. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall...
PCI Biotech interim Q1 2023 results
12. Mai 2023 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 12 May 2023 – PCI Biotech (OSE: PCIB), today announces its interim Q1 2023 results. Please find enclosed the report and presentation. Highlights reviewfimaNAc – bioprocessingThe...
PCI Biotech: Invitation to Q1 2023 results presentation
09. Mai 2023 09:52 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 9 May 2023 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's Q1 2023 interim report on Friday 12 May 2023, 08:30am – 09:30am CEST (local time). The...
PCI Biotech - Notice of Annual General Meeting 2023
04. Mai 2023 04:04 ET
|
PCI Biotech Holding ASA
Oslo, Norway 4 May 2023 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 25 May 2023 at 10:00am (CEST). The...